MAPK14 and amyotrophic lateral sclerosis: Nuclear MAPK14 inhibits NF-κB activity, promotes several transcription factors to make transcriptional changes, and the p38 pathway has been implicated in ALS pathology, particularly with SOD1 and FUS mutations (reviewed in [205]).